Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04535401
Title Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Comprehensive Cancer Center Duarte California 91010 United States Details
National Cancer Institute Developmental Therapeutics Clinic Bethesda Maryland 20892 United States Details
National Institutes of Health Clinical Center Bethesda Maryland 20892 United States Details
Siteman Cancer Center at West County Hospital Creve Coeur Missouri 63141 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Siteman Cancer Center-South County Saint Louis Missouri 63129 United States Details
Siteman Cancer Center at Christian Hospital Saint Louis Missouri 63136 United States Details
Siteman Cancer Center at Saint Peters Hospital Saint Peters Missouri 63376 United States Details
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York New York 10032 United States Details
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field